Takeda Pharmaceutical Company Limited Legal Proceedings Provision
Takeda Pharmaceutical Company Limited (TAK) had Legal Proceedings Provision of JPY 12.46 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:LegalProceedingsProvision · last filed 2025-06-25
- 2025-03-31: Legal Proceedings Provision 12.46B JPY.
- 2024-03-31: Legal Proceedings Provision 22.34B JPY.
- 2023-03-31: Legal Proceedings Provision 64.29B JPY.
- 2022-03-31: Legal Proceedings Provision 42.87B JPY.
| Period end | Legal Proceedings Provision |
|---|---|
| 2025-03-31 | 12.46B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 22.34B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 64.29B JPY 20-F · filed 2024-06-26 |
| 2022-03-31 | 42.87B JPY 20-F · filed 2023-06-28 |
| 2021-03-31 | 73.39B JPY 20-F · filed 2022-06-29 |
| 2020-03-31 | 49.71B JPY 20-F · filed 2021-06-29 |
| 2019-03-31 | 46.77B JPY 20-F · filed 2019-06-27 |